Zen Technologies Fund Raise of ₹979.5 Cr

Zen Technologies Investor Presentation: Key Takeaways

Q2FY27 consolidated revenue ₹345.13 Cr (+98.8% YoY), Operational EBITDA ₹131.99 Cr (38.2% margin), adj PAT ₹89.54 Cr (+50.7%). Order book ₹1,375.70 Cr; indigenous defence technology focus.

Zen Technologies Results Update

Zen Technologies released its Q2 and H1 FY27 unaudited results, reporting consolidated Q2 revenue of ₹345.13 Crore, up 98.8% year-on-year. Order book stands at ₹1,375.70 Crore.

Order book

₹1,376 Cr

Zen Technologies Employee Stock Options

Zen Technologies granted 12,000 ESOPs at ₹500 each under its 2021 scheme. Options vest after one year and are exercisable within two years thereafter.

Zen Technologies Other Announcement

Zen Technologies reported no QIP fund utilisation deviation for the quarter ended September 30, 2026. Rs.737.85 Crore of Rs.979.51 Crore raised is utilised per original objects.

Zen Technologies Q2 FY27 Results: Net Profit ₹101.9 Cr, Up 64.6% YoY

Zen Technologies Ltd reported revenue from operations of ₹345.1 Cr (+98.8% YoY) and net profit of ₹101.9 Cr (+64.6% YoY) for Q2 FY27.

Key figure

Net profit ₹101.9 Cr · +64.6% YoY

Zen Technologies Business Update

ZEN Technologies disclosed that Whole-time Director Shilpa Choudari received Business Today's MPW Award. Union Minister Nitin Gadkari presented it on 23 October 2026.

Rite Zone Chemcon India Fund Raise of ₹6.58 Cr

Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.

Value

₹6.58 Cr

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.